SG10201807904RA - Mitochondria-Targeted Dicarbonyl Sequestering Compounds - Google Patents

Mitochondria-Targeted Dicarbonyl Sequestering Compounds

Info

Publication number
SG10201807904RA
SG10201807904RA SG10201807904RA SG10201807904RA SG10201807904RA SG 10201807904R A SG10201807904R A SG 10201807904RA SG 10201807904R A SG10201807904R A SG 10201807904RA SG 10201807904R A SG10201807904R A SG 10201807904RA SG 10201807904R A SG10201807904R A SG 10201807904RA
Authority
SG
Singapore
Prior art keywords
compounds
mitochondria
targeted
dicarbonyl sequestering
salts
Prior art date
Application number
SG10201807904RA
Other languages
English (en)
Inventor
Michael Murphy
Robin Andrew James Smith
Richard Charles Hartley
Original Assignee
Res & Innovation Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res & Innovation Uk filed Critical Res & Innovation Uk
Publication of SG10201807904RA publication Critical patent/SG10201807904RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Dentistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG10201807904RA 2013-11-22 2014-11-21 Mitochondria-Targeted Dicarbonyl Sequestering Compounds SG10201807904RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1320636.2A GB201320636D0 (en) 2013-11-22 2013-11-22 Compounds

Publications (1)

Publication Number Publication Date
SG10201807904RA true SG10201807904RA (en) 2018-10-30

Family

ID=49918047

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201807904RA SG10201807904RA (en) 2013-11-22 2014-11-21 Mitochondria-Targeted Dicarbonyl Sequestering Compounds
SG11201603485TA SG11201603485TA (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201603485TA SG11201603485TA (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Country Status (12)

Country Link
US (1) US9963474B2 (cg-RX-API-DMAC7.html)
EP (2) EP3623375A1 (cg-RX-API-DMAC7.html)
JP (1) JP6661533B2 (cg-RX-API-DMAC7.html)
CN (1) CN105873936B (cg-RX-API-DMAC7.html)
AU (1) AU2014351802B2 (cg-RX-API-DMAC7.html)
CA (1) CA2931000A1 (cg-RX-API-DMAC7.html)
ES (1) ES2802123T3 (cg-RX-API-DMAC7.html)
GB (1) GB201320636D0 (cg-RX-API-DMAC7.html)
HK (1) HK1226079A1 (cg-RX-API-DMAC7.html)
SG (2) SG10201807904RA (cg-RX-API-DMAC7.html)
WO (1) WO2015075200A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201603129B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503280A (ja) * 2016-12-29 2020-01-30 ウニヴェルシダージ ド ポルトUniversidade Do Porto ヒドロキシ安息香酸誘導体、その方法および使用
JP6985730B2 (ja) * 2017-11-17 2021-12-22 株式会社日立ハイテクサイエンス 試料分析システム、表示方法及び試料分析方法
KR101920902B1 (ko) * 2017-12-27 2018-11-21 전남대학교 산학협력단 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도
WO2020036329A1 (ko) * 2018-08-16 2020-02-20 숙명여자대학교산학협력단 미토콘드리아 내 nad(p)h 검출을 위한 형광 프로브 및 이를 이용한 검출방법
AU2020212612B2 (en) * 2019-01-25 2025-07-31 Naji Abumrad Triphenylphosphonium-tethered salicylamine derivatives
EP3914077A4 (en) * 2019-01-25 2022-11-30 Vanderbilt University MITOCHONDRIAL TARGETING ISOKETAL/ISOLEVUGLANDIN SCAVENGERS
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2021154877A1 (en) * 2020-01-27 2021-08-05 Vanderbilt University Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB926998A (en) * 1960-04-25 1963-05-22 Ici Ltd New water-soluble azo dyestuffs containing phosphonium groups
JPS52806A (en) 1975-02-20 1977-01-06 Dai Ichi Kogyo Seiyaku Co Ltd Preparation of ester
JPS6029391B2 (ja) 1976-02-04 1985-07-10 富士写真フイルム株式会社 ベンゾトリアゾ−ル化合物
FR2776289B1 (fr) * 1998-03-20 2001-02-02 Oreal Composition de teinture d'oxydation contenant un coupleur cationique, procedes de teinture, nouveaux coupleurs cationiques
FR2776290B1 (fr) * 1998-03-20 2001-08-10 Oreal Nouveaux composes cationiques, leur utilisation comme coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
FR2788520B1 (fr) * 1999-01-19 2003-02-28 Oreal Nouveaux colorants mono-benzeniques cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
WO2002058659A1 (en) * 2001-01-23 2002-08-01 P&G-Clairol, Inc. Couplers for oxidative coloration of hair
AU2003258664A1 (en) * 2002-09-02 2004-03-19 Ciba Specialty Chemicals Holding Inc. Method of colouring porous material
JPWO2006059423A1 (ja) * 2004-12-02 2008-06-05 独立行政法人科学技術振興機構 過興奮性の細胞傷害によって生じる疾患を治療するための薬剤および方法
US7956193B2 (en) * 2007-05-04 2011-06-07 University Of South Florida Intramolecular C-H amination with sulfonyl azides
CA2699794C (en) 2007-09-10 2016-07-19 University Of Massachusetts Mitochondria-targeted anti-tumor agents
FR2984321A1 (fr) * 2011-12-16 2013-06-21 Oreal Paraphenylenediamines cationiques, composition comprenant au moins de tels composes, procede de mise en oeuvre et utilisation
CN102617467A (zh) * 2012-02-21 2012-08-01 大连理工大学 一种检测一氧化氮的超高灵敏荧光探针
FR2996552B1 (fr) * 2012-08-17 2016-10-14 Oreal Composition tinctoriale comprenant un derive o-alkyle substitue de meta-phenylenediamine cationique

Also Published As

Publication number Publication date
CA2931000A1 (en) 2015-05-28
EP3623375A1 (en) 2020-03-18
AU2014351802B2 (en) 2019-10-03
WO2015075200A1 (en) 2015-05-28
CN105873936A (zh) 2016-08-17
GB201320636D0 (en) 2014-01-08
CN105873936B (zh) 2018-09-14
ZA201603129B (en) 2018-12-19
US20160289252A1 (en) 2016-10-06
AU2014351802A1 (en) 2016-05-26
ES2802123T3 (es) 2021-01-15
NZ719705A (en) 2021-09-24
EP3071582A1 (en) 2016-09-28
EP3071582B1 (en) 2020-04-29
HK1226079A1 (zh) 2017-09-22
US9963474B2 (en) 2018-05-08
JP6661533B2 (ja) 2020-03-11
JP2017504561A (ja) 2017-02-09
SG11201603485TA (en) 2016-05-30

Similar Documents

Publication Publication Date Title
HK1226079A1 (zh) 线粒体靶向的二羰基螯合化合物
CY1123670T1 (el) Κρυσταλλικο παραγωγο 6,7-ακορεστης-7-καρβαμοϋλ μορφινανης, και μεθοδος για την παραγωγη αυτου
BR112013020996A8 (pt) derivados aminobutíricos substituídos como inibidores de neprilisina
MA37206B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JO3453B1 (ar) مشتقات البنزاميد لتثبيط نشاط abl1 و abl2 و bcr-abl1
JO3577B1 (ar) صيغ صيدلانية تشمل مشتقات 1-(بيتا-d- غلوكوبيرانوسيل) -2-ثينيل ميثيل بنزين كمثبطات sglt
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
MA32941B1 (fr) Composes organiques
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
IN2014MN02106A (cg-RX-API-DMAC7.html)
PH12014501283A1 (en) 4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
CY1120515T1 (el) Παραγωγο κυκλοαλκυλικο οξεος, μεθοδος παρασκευης και φαρμακευτικη εφαρμογη αυτου
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
EA201270302A1 (ru) Безводные формы производных пиридина
CY1117397T1 (el) Παραγωγα 3-ετεροαρουλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
CY1118844T1 (el) Υποκατεστημενα παραγωγα 3-ετεροαροϋλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
MX2016001095A (es) Sales de dasatinib en forma cristalina.
CY1120101T1 (el) Παραγωγο πυριδονης και φαρμακο που το περιεχει
CY1114704T1 (el) Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν
BR112018007673A2 (pt) ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos?
EA201390488A1 (ru) Новые агонисты gpr 119